In Conversation with Kevin Hannigan, President of Lab Owl®/Automated Control Concepts, Inc.

Published on :

Personalized and regenerative medicines are promising but they are complex to develop and require highly-flexible advanced manufacturing techniques that are still too manually intensive and costly.